Yoo: CMS will launch payment guidance for breakthrough therapies despite election delays
Julie Yoo · Big Ideas in 2024: Democratizing “Miracle Drugs” with Julie Yoo · Dec 11, 2023 · at 21:41
Julie Yoo, General Partner at Andreessen Horowitz, discusses how regulatory bodies and government insurance administrators must adapt payment models for costly new drugs like GLP-1s and gene therapies.
0:00 / 0:31exact quote · 31.7s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“And then CMS, which administers Medicare and Medicaid the government sponsored insurance programs in our country. They generally tend to be at the tip of the spear of any payment innovation for new classes of drugs and new classes of services. And so the expectation is that they will likely roll out some sort of program that you know, teaches the industry how they should be approaching these kinds of therapies and financing them. And so, but, you know, we're in an election year, and so I think expectations are that that cycle will be slow.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Julie Yoo
Yoo: AI task unbundling could nearly double clinical workforce capacity
“So, you know, imagine like almost doubling the capacity of a given clinical labor pool simply by applying some of these unbundling tactics.”
Yoo: Healthcare's lack of SaaS legacy enables faster AI adoption
“One of the dynamics that we believe is driving this rapid adoption cycle of these new AI tools is what we call this kind of leapfrog dynamic, where, you know, healthcare historically has been a laggard with respect to software-based technology. And we've alway…”
Yoo: Healthcare AI will increasingly be sold as digital labor
“We're at a breaking point where the industry needs these solutions, and therefore we're going to see a much higher adoption than we've ever seen before. I think it will come in the form of these super staff. I think we will increasingly see adoption of these A…”
Yoo: AI insurance lawsuits stem from denial speed, not denial rates
“The rate of denials is not going up, it's the speed with which the denials are happening that's going up.”
Yoo: Pandemic accelerates 10-year healthcare modernization trends into 2-3 years
“Now, all of those things were tailwinds that we thought would take 10 years or even longer to play out. But with the current dynamics at play during this pandemic it's more likely that those things will play out in two or three years.”